The aims of current asthma treatment are to suppress airway inflammation and control
symptoms, and corticosteroids maintain a commanding position in this role. Steroids …

Introduction: It is recognized that airway inflammation is key to asthma pathogenesis.
Biopharmaceutical approaches have identified new therapies that target key cells and …

The field of asthma has undergone a dramatic change in recent years. Advances in our
understanding of type 2 airway inflammation have driven the discovery of monoclonal …

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow
limitation that is usually progressive and associated with chronic inflammation of the …

Cytokines are key players in the initiation and propagation of inflammation in chronic
inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD) …

While considerable progress has been made in development of drugs for asthma, there
have been few advances in the treatment of chronic obstructive pulmonary disease (COPD) …

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating condition
with declining lung function associated with airway inflammation, mucus hypersecretion and …

Asthma and chronic obstructive pulmonary disease (COPD) are both obstructive airway
diseases that involve chronic inflammation of the respiratory tract, but the type of …

Cytokines play a critical role in orchestrating and perpetuating inflammation in asthmatic
airways and several specific cytokine and chemokine inhibitors are now in development for …

Today inhaled corticosteroids (ICS) are regarded as the first-line controller anti-inflammatory
treatment in the management of asthma. However, there is an increasing awareness of the …